Miranda Machacek, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Acetylglucosamine | 3 | 2020 | 189 | 1.320 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2020 | 1974 | 0.820 |
Why?
|
| Hamartoma | 1 | 2023 | 235 | 0.750 |
Why?
|
| Inclusion Bodies | 1 | 2020 | 281 | 0.650 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2020 | 647 | 0.590 |
Why?
|
| Peptide Hydrolases | 1 | 2020 | 624 | 0.580 |
Why?
|
| Oligonucleotides | 1 | 2020 | 582 | 0.580 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2020 | 258 | 0.570 |
Why?
|
| Tuberous Sclerosis | 1 | 2023 | 1030 | 0.500 |
Why?
|
| Interleukin-17 | 1 | 2019 | 912 | 0.420 |
Why?
|
| Th17 Cells | 1 | 2019 | 794 | 0.410 |
Why?
|
| Fatty Acids | 1 | 2019 | 1808 | 0.370 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2023 | 3165 | 0.300 |
Why?
|
| Enzyme Assays | 3 | 2015 | 104 | 0.290 |
Why?
|
| beta-N-Acetylhexosaminidases | 2 | 2017 | 44 | 0.280 |
Why?
|
| Kidney Neoplasms | 1 | 2023 | 4251 | 0.270 |
Why?
|
| Macrophages | 1 | 2020 | 5769 | 0.250 |
Why?
|
| N-Acetylglucosaminyltransferases | 2 | 2017 | 167 | 0.250 |
Why?
|
| Leptospirosis | 1 | 2024 | 31 | 0.240 |
Why?
|
| Jaundice | 1 | 2024 | 94 | 0.230 |
Why?
|
| Ornithine-Oxo-Acid Transaminase | 1 | 2023 | 49 | 0.220 |
Why?
|
| Sulfotransferases | 2 | 2015 | 150 | 0.210 |
Why?
|
| Polyamines | 1 | 2023 | 133 | 0.200 |
Why?
|
| Glycosyltransferases | 2 | 2015 | 116 | 0.200 |
Why?
|
| Glycosylation | 2 | 2020 | 1097 | 0.170 |
Why?
|
| Histocytochemistry | 1 | 2020 | 698 | 0.170 |
Why?
|
| Acylation | 1 | 2019 | 96 | 0.160 |
Why?
|
| Phosphoric Monoester Hydrolases | 2 | 2012 | 412 | 0.160 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2019 | 72 | 0.160 |
Why?
|
| Pyrans | 1 | 2019 | 49 | 0.160 |
Why?
|
| Immunoprecipitation | 1 | 2020 | 878 | 0.150 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2019 | 152 | 0.150 |
Why?
|
| Fever | 1 | 2024 | 1618 | 0.140 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2019 | 4369 | 0.130 |
Why?
|
| Respiratory Insufficiency | 1 | 2024 | 1230 | 0.130 |
Why?
|
| Transcriptional Activation | 1 | 2019 | 1756 | 0.110 |
Why?
|
| Glycosaminoglycans | 1 | 2015 | 607 | 0.100 |
Why?
|
| Thiazoles | 1 | 2019 | 1517 | 0.100 |
Why?
|
| Mitosis | 1 | 2016 | 1188 | 0.090 |
Why?
|
| Golgi Apparatus | 1 | 2012 | 405 | 0.090 |
Why?
|
| Disease Management | 1 | 2020 | 2508 | 0.090 |
Why?
|
| Dimethylallyltranstransferase | 1 | 2009 | 8 | 0.080 |
Why?
|
| Terpenes | 1 | 2009 | 96 | 0.080 |
Why?
|
| Protein Binding | 2 | 2019 | 9353 | 0.080 |
Why?
|
| Kidney | 1 | 2023 | 7047 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 1 | 2019 | 5790 | 0.070 |
Why?
|
| Lymphocyte Activation | 1 | 2018 | 5485 | 0.070 |
Why?
|
| Energy Metabolism | 1 | 2017 | 2882 | 0.070 |
Why?
|
| Pancreatic Neoplasms | 1 | 2023 | 5369 | 0.060 |
Why?
|
| Leptospira | 1 | 2024 | 13 | 0.060 |
Why?
|
| Cytokines | 1 | 2019 | 7396 | 0.060 |
Why?
|
| Mitochondria | 1 | 2017 | 3624 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 2 | 2019 | 22172 | 0.050 |
Why?
|
| Ornithine | 1 | 2023 | 79 | 0.050 |
Why?
|
| Humans | 12 | 2024 | 761572 | 0.050 |
Why?
|
| Doxycycline | 1 | 2024 | 344 | 0.050 |
Why?
|
| Rosaniline Dyes | 2 | 2012 | 50 | 0.050 |
Why?
|
| Animals | 5 | 2023 | 168467 | 0.050 |
Why?
|
| Mice | 4 | 2023 | 81533 | 0.040 |
Why?
|
| Metabolomics | 1 | 2009 | 1659 | 0.040 |
Why?
|
| Arginine | 1 | 2023 | 934 | 0.040 |
Why?
|
| Phosphates | 2 | 2015 | 770 | 0.040 |
Why?
|
| Kinetics | 3 | 2012 | 6374 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2024 | 64684 | 0.040 |
Why?
|
| Obesity | 1 | 2019 | 12947 | 0.030 |
Why?
|
| Radioactivity | 1 | 2015 | 59 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 58986 | 0.030 |
Why?
|
| Recombinant Proteins | 2 | 2015 | 6534 | 0.030 |
Why?
|
| Biopsy | 1 | 2024 | 6766 | 0.030 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2023 | 1728 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 1612 | 0.020 |
Why?
|
| Reference Standards | 1 | 2015 | 1003 | 0.020 |
Why?
|
| Glucosyltransferases | 1 | 2010 | 96 | 0.020 |
Why?
|
| Sialyltransferases | 1 | 2010 | 83 | 0.020 |
Why?
|
| Colorimetry | 1 | 2010 | 150 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2016 | 3094 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 3877 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2017 | 6132 | 0.020 |
Why?
|
| Pliability | 1 | 2009 | 59 | 0.020 |
Why?
|
| Prenylation | 1 | 2009 | 37 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2024 | 12975 | 0.020 |
Why?
|
| Diphosphates | 1 | 2009 | 84 | 0.020 |
Why?
|
| Naphthoquinones | 1 | 2009 | 58 | 0.020 |
Why?
|
| Adult | 2 | 2024 | 221203 | 0.020 |
Why?
|
| Streptomyces | 1 | 2009 | 91 | 0.020 |
Why?
|
| Liver | 1 | 2024 | 7529 | 0.020 |
Why?
|
| Diterpenes | 1 | 2009 | 171 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2012 | 1791 | 0.020 |
Why?
|
| Male | 3 | 2024 | 360842 | 0.020 |
Why?
|
| Bacterial Proteins | 2 | 2010 | 3847 | 0.020 |
Why?
|
| Aged | 1 | 2019 | 169310 | 0.020 |
Why?
|
| Lung | 1 | 2024 | 10002 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2016 | 8321 | 0.020 |
Why?
|
| Bacterial Toxins | 1 | 2010 | 932 | 0.020 |
Why?
|
| Middle Aged | 1 | 2019 | 220920 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2017 | 14416 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2024 | 20571 | 0.010 |
Why?
|
| Binding Sites | 1 | 2009 | 6056 | 0.010 |
Why?
|
| Female | 1 | 2019 | 392686 | 0.010 |
Why?
|
| Proteins | 1 | 2010 | 6032 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2016 | 23447 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 20099 | 0.010 |
Why?
|